1.
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
by Griffiths, Paul D, Prof
The Lancet (British edition), 2011, Vol.377 (9773), p.1256-1263
Filter electronic articles 1 Hits
Remove Filters
- Subjects
- Cytomegalovirus Infections - Dia... (1)
- Cytomegalovirus - Isolation & Purification
- Cytomegalovirus - Immunology (1)
- more ...
- Cytomegalovirus - Genetics (1)
- Cytomegalovirus Infections - Pre... (1)
- Cytomegalovirus Vaccines - Admin... (1)
- Design (1)
- Cytomegaloviruses (1)
- Cytomegalovirus Vaccines - Pharm... (1)
- Cytomegalovirus (1)
- Clinical Trials (1)
- Aged (1)
- Adult
- Adjuvants, Immunologic - Adminis... (1)
- Albumin (1)
- Antibodies (1)
- Blood Products (1)
- Biological And Medical Sciences (1)
- Antibodies, Viral - Isolation &a... (1)
- Adjuvants (1)
- less ...